FABBRI, ALBERTO
FABBRI, ALBERTO
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience
2019-01-01 Cencini, E.; Fabbri, A.; Sicuranza, A.; Santoni, Adele; Bocchia, M.
How to manage early-stage follicular lymphoma
2020-01-01 Cencini, Emanuele; Fabbri, Alberto; Mecacci, Bianca; Bocchia, Monica
Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case series
2020-01-01 Fabbri, Alberto; Cencini, Emanuele; Congiu, Angela Giovanna; Miglino, Maurizio; Rigacci, Luigi; Bocchia, Monica
Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma?
2020-01-01 Cencini, E; Fabbri, A; Mecacci, B; Bocchia, M
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the “RTL” (Regional Tuscan Lymphoma network)
2022-01-01 Cencini, E; Mecacci, B.; Rocco, M.; Innocenti, F.; Ghio, F.; Puccini, B.; Della Seta, R.; Simonetti, F.; Mannelli, L.; Cuccaro, A.; Bocchia, M.; Fabbri, A.
Prognostic impact of tumor-associated macrophages, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma
2020-01-01 Cencini, Emanuele; Fabbri, Alberto; Schiattone, Luana; Sicuranza, Anna; Mecacci, Bianca; Granai, Massimo; Mancini, Virginia; Lazzi, Stefano; Bocchia, Monica; Leoncini, Lorenzo
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data
2020-01-01 Roberto, G.; Spini, A.; Bartolini, C.; Moscatelli, V.; Barchielli, A.; Paoletti, D.; Giorgi, S.; Fabbri, A.; Bocchia, M.; Donnini, S.; Gini, R.; Ziche, M.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi
2023-01-01 Cencini, E.; Tucci, A.; Puccini, B.; Cavallo, F.; Luminari, S.; Usai, S. V.; Fabbri, A.; Pennese, E.; Marino, D.; Zilioli, V. R.; Balzarotti, M.; Petrucci, L.; Tafuri, A.; Arcari, A.; Botto, B.; Zanni, M.; Hohaus, S.; Sartori, R.; Merli, M.; Gini, G.; Al Essa, W.; Musurca, G.; Tani, M.; Nassi, L.; Daffini, R.; Mammi, C.; Marcheselli, L.; Bocchia, M.; Spina, M.; Merli, F.
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications
2023-01-01 Cencini, E.; Sicuranza, A.; Ciofini, S.; Fabbri, A.; Bocchia, M.; Gozzetti, A.
Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications
2023-01-01 Bartolini, C.; Roberto, G.; Girardi, A.; Moscatelli, V.; Spini, A.; Barchielli, A.; Bocchia, M.; Fabbri, A.; Donnini, S.; Ziche, M.; Monti, M. C.; Gini, R.
Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
---|---|---|---|---|
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience | 1-gen-2019 | Cencini, E.; Fabbri, A.; Sicuranza, A.; Santoni, Adele; Bocchia, M. | - | |
How to manage early-stage follicular lymphoma | 1-gen-2020 | Cencini, Emanuele; Fabbri, Alberto; Mecacci, Bianca; Bocchia, Monica | - | |
Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case series | 1-gen-2020 | Fabbri, Alberto; Cencini, Emanuele; Congiu, Angela Giovanna; Miglino, Maurizio; Rigacci, Luigi; Bocchia, Monica | - | |
Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma? | 1-gen-2020 | Cencini, E; Fabbri, A; Mecacci, B; Bocchia, M | - | |
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the “RTL” (Regional Tuscan Lymphoma network) | 1-gen-2022 | Cencini, E; Mecacci, B.; Rocco, M.; Innocenti, F.; Ghio, F.; Puccini, B.; Della Seta, R.; Simonetti, F.; Mannelli, L.; Cuccaro, A.; Bocchia, M.; Fabbri, A. | - | |
Prognostic impact of tumor-associated macrophages, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma | 1-gen-2020 | Cencini, Emanuele; Fabbri, Alberto; Schiattone, Luana; Sicuranza, Anna; Mecacci, Bianca; Granai, Massimo; Mancini, Virginia; Lazzi, Stefano; Bocchia, Monica; Leoncini, Lorenzo | - | |
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data | 1-gen-2020 | Roberto, G.; Spini, A.; Bartolini, C.; Moscatelli, V.; Barchielli, A.; Paoletti, D.; Giorgi, S.; Fabbri, A.; Bocchia, M.; Donnini, S.; Gini, R.; Ziche, M. | - | |
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi | 1-gen-2023 | Cencini, E.; Tucci, A.; Puccini, B.; Cavallo, F.; Luminari, S.; Usai, S. V.; Fabbri, A.; Pennese, E.; Marino, D.; Zilioli, V. R.; Balzarotti, M.; Petrucci, L.; Tafuri, A.; Arcari, A.; Botto, B.; Zanni, M.; Hohaus, S.; Sartori, R.; Merli, M.; Gini, G.; Al Essa, W.; Musurca, G.; Tani, M.; Nassi, L.; Daffini, R.; Mammi, C.; Marcheselli, L.; Bocchia, M.; Spina, M.; Merli, F. | - | |
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications | 1-gen-2023 | Cencini, E.; Sicuranza, A.; Ciofini, S.; Fabbri, A.; Bocchia, M.; Gozzetti, A. | - | |
Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications | 1-gen-2023 | Bartolini, C.; Roberto, G.; Girardi, A.; Moscatelli, V.; Spini, A.; Barchielli, A.; Bocchia, M.; Fabbri, A.; Donnini, S.; Ziche, M.; Monti, M. C.; Gini, R. | - |